A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety

Placebo may yield beneficial effects that are indistinguishable from those of active medication, but the factors underlying proneness to respond to placebo are widely unknown. Here, we used functional neuroimaging to examine neural correlates of anxiety reduction resulting from sustained placebo treatment under randomized double-blind conditions, in patients with social anxiety disorder. Brain activity was assessed during a stressful public speaking task by means of positron emission tomography before and after an 8 week treatment period. Patients were genotyped with respect to the serotonin transporter-linked polymorphic region (5-HTTLPR) and the G-703T polymorphism in the tryptophan hydroxylase-2 (TPH2) gene promoter. Results showed that placebo response was accompanied by reduced stress-related activity in the amygdala, a brain region crucial for emotional processing. However, attenuated amygdala activity was demonstrable only in subjects who were homozygous for the long allele of the 5-HTTLPR or the G variant of the TPH2 G-703T polymorphism, and not in carriers of short or T alleles. Moreover, the TPH2 polymorphism was a significant predictor of clinical placebo response, homozygosity for the G allele being associated with greater improvement in anxiety symptoms. Path analysis supported that the genetic effect on symptomatic improvement with placebo is mediated by its effect on amygdala activity. Hence, our study shows, for the first time, evidence of a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced anxiety relief.

[1]  Eliza Congdon,et al.  Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing , 2008, Biological Psychology.

[2]  T. Furmark,et al.  Imaging the placebo response: A neurofunctional review , 2008, European Neuropsychopharmacology.

[3]  Patrick M Fisher,et al.  Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity , 2008, Neuropsychopharmacology.

[4]  Richard J. Davidson,et al.  A Functional Magnetic Resonance Imaging Predictor of Treatment Response to Venlafaxine in Generalized Anxiety Disorder , 2008, Biological Psychiatry.

[5]  A. Simmons,et al.  Escitalopram effects on insula and amygdala BOLD activation during emotional processing , 2008, Psychopharmacology.

[6]  R. Peeters,et al.  Amygdala Hyperfunction in Phobic Fear Normalizes After Exposure , 2007, Biological Psychiatry.

[7]  A. Kersting,et al.  Serotonergic genes modulate amygdala activity in major depression , 2007, Genes, brain, and behavior.

[8]  M. Alex Dresner,et al.  Human 5-HT Transporter Availability Predicts Amygdala Reactivity In Vivo , 2007, The Journal of Neuroscience.

[9]  Robert A. Koeppe,et al.  Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects , 2007, Neuron.

[10]  J. Zubieta,et al.  Placebo effects on human μ-opioid activity during pain , 2007, Proceedings of the National Academy of Sciences.

[11]  A. Newberg,et al.  Cerebral blood flow changes during retrieval of traumatic memories before and after psychotherapy: a SPECT study , 2007, Psychological Medicine.

[12]  A. Serretti,et al.  Serotonin transporter gene variants and behavior: a comprehensive review. , 2006, Current drug targets.

[13]  Dan J Stein,et al.  Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. , 2006, The Journal of clinical psychiatry.

[14]  A. Hariri,et al.  Capacity for 5-HT1A–mediated autoregulation predicts amygdala reactivity , 2006, Nature Neuroscience.

[15]  Justin S. Feinstein,et al.  Lorazepam dose-dependently decreases risk-taking related activation in limbic areas , 2006, Psychopharmacology.

[16]  K. Lesch,et al.  Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. , 2006, Cerebral cortex.

[17]  Guy M. Goodwin,et al.  Antidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues , 2006, Biological Psychiatry.

[18]  A. Hariri,et al.  Genetics of emotional regulation: the role of the serotonin transporter in neural function , 2006, Trends in Cognitive Sciences.

[19]  M. Stein,et al.  Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder , 2006, Psychopharmacology.

[20]  Daniel A. Fitzgerald,et al.  Association between Amygdala Hyperactivity to Harsh Faces and Severity of Social Anxiety in Generalized Social Phobia , 2006, Biological Psychiatry.

[21]  D. Amaral,et al.  The distribution of serotonergic fibers in the macaque monkey amygdala: An immunohistochemical study using antisera to 5-hydroxytryptamine , 2005, Neuroscience.

[22]  J. Zubieta,et al.  Neurobiological Mechanisms of the Placebo Effect , 2005, The Journal of Neuroscience.

[23]  R. T. Constable,et al.  Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation , 2005, Journal of Neural Transmission.

[24]  A. Hariri,et al.  A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity , 2005, Molecular Psychiatry.

[25]  Thomas E. Nichols,et al.  Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors , 2005, The Journal of Neuroscience.

[26]  T. Furmark,et al.  Cerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo , 2005, Biological Psychiatry.

[27]  T. Dietrich,et al.  Placebo in Emotional Processing— Induced Expectations of Anxiety Relief Activate a Generalized Modulatory Network , 2005, Neuron.

[28]  Justin S. Feinstein,et al.  Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. , 2005, Archives of general psychiatry.

[29]  Andreas Heinz,et al.  Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex , 2005, The Journal of Neuroscience.

[30]  J. Lorberbaum,et al.  Neural correlates of speech anticipatory anxiety in generalized social phobia , 2004, Neuroreport.

[31]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[32]  Mats Fredrikson,et al.  Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia , 2004, Neuroscience Letters.

[33]  Edward E. Smith,et al.  Placebo-Induced Changes in fMRI in the Anticipation and Experience of Pain , 2004, Science.

[34]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[35]  M. Liebowitz,et al.  Evaluation of the Clinical Global Impression Scale among individuals with social anxiety disorder , 2003, Psychological Medicine.

[36]  T. Furmark,et al.  Cerebral blood flow during anticipation of public speaking in social phobia: a PET study , 2002, Biological Psychiatry.

[37]  Gregory G. Brown,et al.  Increased amygdala activation to angry and contemptuous faces in generalized social phobia. , 2002, Archives of general psychiatry.

[38]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[39]  T. Furmark,et al.  Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. , 2002, Archives of general psychiatry.

[40]  P. Jerabek,et al.  The functional neuroanatomy of the placebo effect. , 2002, The American journal of psychiatry.

[41]  Jun Yu Li,et al.  Initial conditions of serotonin transporter kinetics and genotype: influence on ssri treatment trial outcome , 2002, Biological Psychiatry.

[42]  P. Petrovic,et al.  Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network , 2002, Science.

[43]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[44]  M Schulzer,et al.  Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease , 2001, Science.

[45]  H Fischer,et al.  Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. , 2001, The American journal of psychiatry.

[46]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[47]  L. Sher.  The role of the endogenous opioid system in the pathogenesis of anxiety disorders. , 1998, Medical hypotheses.

[48]  R. Mattick,et al.  Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. , 1998, Behaviour research and therapy.

[49]  Henry Kranzler,et al.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects , 1997, Human Genetics.

[50]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[51]  Denis Dooley,et al.  Atlas of the Human Brain. , 1971 .

[52]  H. Beecher,et al.  The powerful placebo. , 1955, Journal of the American Medical Association.

[53]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[54]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[55]  J. Angst,et al.  Social phobia. , 1995, European archives of psychiatry and clinical neuroscience.

[56]  J. E. Davis,et al.  Crossing cultural divides: moral conflict and the Cairo population conference. , 1995, Virginia review of sociology.

[57]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[58]  Adrian E. Raftery,et al.  Bayesian Model Selection in Structural Equation Models , 1992 .